DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC

Institutional investor · Portfolio as of Q1 2021

SEC EDGAR SourceSEC Filings

Top Holdings435 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

3M$350.3M5.2%$38.34+177.01%
9 qtrssince 2019-Q1
Decreased
0
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

630,016$142.8M2.1%$182.58+19.24%
9 qtrssince 2019-Q1
Decreased
0
HDBHDB
ADR

HDFC BANK LTD-ADR

1.5M$113.3M1.7%$25.85+45.36%
9 qtrssince 2019-Q1
Decreased
0
IBNIBN
ADR

ICICI BANK LTD-SPON ADR

6.1M$97.7M1.4%$11.47+35.10%
9 qtrssince 2019-Q1
Increased
52

EPAM SYSTEMS INC

237,005$94M1.4%$337.68+13.57%
9 qtrssince 2019-Q1
Increased
56

SPRINGWORKS THERAPEUTICS INC

1.3M$92.9M1.4%
7 qtrssince 2019-Q3
Increased
51

VISA INC-CLASS A SHARES

422,981$89.6M1.3%$207.17-1.88%
2 qtrssince 2020-Q4
Increased
69

RELAY THERAPEUTICS INC

2.5M$87.9M1.3%$37.51-5.15%
3 qtrssince 2020-Q3
Increased
76

NATERA INC

771,185$78.3M1.2%$32.01+203.51%
8 qtrssince 2019-Q2
Decreased
0
BIDUBIDU
ADR

BAIDU INC - SPON ADR

352,806$76.8M1.1%$218.230.00%
1 qtr
New
68

MICRON TECHNOLOGY INC

855,536$75.5M1.1%$74.51+13.32%
2 qtrssince 2020-Q4
Increased
63

CYTOKINETICS INC

3.2M$75.3M1.1%$12.27+82.02%
8 qtrssince 2019-Q2
Increased
47

ULTRA CLEAN HLDGS INC

1.3M$74.7M1.1%$33.33+66.34%
6 qtrssince 2019-Q4
Increased
64
NVTAQNVTAQDelisted

INVITAE CORP

1.8M$68.3M1.0%
4 qtrssince 2020-Q2
Increased
67

GROWGENERATION CORP

1.3M$65M1.0%$8.39+428.59%
4 qtrssince 2020-Q2
Decreased
0
VALEVALE
ADR

VALE SA-SP ADR

3.7M$64.5M1.0%$10.190.00%
1 qtr
New
58

CHART INDS INC

433,759$61.7M0.9%$80.06+72.46%
6 qtrssince 2019-Q4
Increased
43

ADAPTHEALTH CORP

1.7M$60.7M0.9%$22.11-73.72%
5 qtrssince 2020-Q1
Increased
43

CALIX INC

1.7M$59M0.9%$27.13+22.83%
3 qtrssince 2020-Q3
Increased
47

MAGNITE INC

1.4M$58.8M0.9%$31.30+29.90%
2 qtrssince 2020-Q4
Decreased
0
$6.8B
AUM
435
Positions
Q1 2021
Filing
Rating · 2.0
Quarterly Portfolio Change
+22%Q4'19$3.8B-20%Q1'20$3B+37%Q2'20$4.1B+18%Q3'20$4.9B+27%Q4'20$6.2B+10%Q1'21$6.8B
Activity profile
$ moved · Q1'21
New29%Increased26%Decreased23%Exited21%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.9 quarters
<1Q24%1-4Q26%1-2Y24%2Y+26%

DRIEHAUS CAPITAL MANAGEMENT LLC manages $6.8B across 435 positions as of Q1 2021. Top holdings: TSM (5.2%), BABA (2.1%), HDB (1.7%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q1 2021 Summary

Active quarter - 141 new positions, 119 exits, 152 increased. Top move: RLAY (INCREASED, conviction 76). Portfolio: $6.8B across 435 positions.

Top holdings by portfolio weight

Total AUM$7B
TSM5.17%
BABA2.11%
HDB1.67%
IBN1.44%
EPAM1.39%
SWTX1.37%
V1.32%
RLAY1.30%
NTRA1.16%
BIDU1.13%
Other1.11%

Portfolio allocation by GICS sector

Sectors11
Technology22.23%
Unknown18.57%
Consumer Cyclical14.95%
Healthcare13.97%
Financial Services9.14%
Industrials8.57%
Communication Services4.20%
Basic Materials3.32%
Consumer Defensive2.55%
Energy1.68%
Other0.83%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Technology, Unknown, Consumer Cyclical
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record66
Conviction43
Concentration25
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
EWTXEWTXEDGEWISE THERAPEUTICS INC
Q2 2025 Q2 2026+3.4M shares+$161.9M
5Q
IMAXIMAXIMAX CORP
Q2 2025 Q2 2026+1.9M shares+$82.1M
4Q
IMNMIMNMIMMUNOME INC
Q3 2025 Q2 2026+4.1M shares+$90M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used